CURVE THERAPEUTICS
LIVE

Serial Number

79335582

Owner

Curve Therapeutics Limited

Attorney

Bruce S. Londa

Filing Date

Jul 13, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CURVE THERAPEUTICS Trademark

Serial Number: 79335582

CURVE THERAPEUTICS is a trademark filed by Curve Therapeutics Limited on July 13, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Curve Therapeutics Limited (4 trademarks)

158-160 North Gower Street

Entity Type: 99

Trademark Details

Filing Date

July 13, 2021

Registration Date

Not Registered

Goods & Services

Pharmaceuticals, namely, pharmaceutical preparations for the treatment of cancer and neurological diseases; medical and veterinary preparations for treatment of cancer and neurological diseases; sanitary preparations for medical purposes; dietetic food and dietetic preparations adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; pharmaceuticals for use in oncology for the treatment of cancer and neurological diseases

Chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations, namely, biologically compatible chemical substances for scientific, laboratory, clinical and medical research; biological tissue, namely, mammalian soft and hard tissues comprising or derived from stem cells or progenitor cells for scientific, laboratory, clinical and medical research; biological tissue, namely, biological tissue comprising or derived from stem cells or progenitor cells, and compositions thereof, for scientific, laboratory, clinical and medical research

Drug discovery and pharmaceutical drug development services; scientific services in the nature of scientific research, analysis, and testing in the field of pharmaceuticals and research, development and design relating thereto; medical research; technological services in the nature of pharmaceutical products development and technical consulting in the field of pharmaceutical studies and research and design relating thereto; product design and development of medical technology in the field of pharmaceuticals; product design and development of medical diagnostic apparatus; consultancy services in the field of technological development in the field of medical technology and pharmaceuticals; industrial analysis and industrial research services in the field of medical technology and pharmaceuticals; design and development of computer hardware and software in the field of clinical trials for pharmaceuticals; design and development of software in the field of clinical trials for pharmaceuticals; clinical research, namely, conducting clinical trials for others; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; medical and scientific research, namely, conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; scientific screening and assaying, namely, scientific research; chemical analysis; chemical research; biotechnology research; consultancy in the field of biotechnology

Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health services relating to antibodies, immuno-oncology, inflammation, haematology and infectious disease, namely, medical diagnostic testing, monitoring and reporting services; medical screening and assaying in the nature of medical testing for diagnostic or treatment purposes

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 8, 2026 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 26, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 24, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 23, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 22, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 20, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 19, 2024 RCSC
ASSIGNED TO EXAMINER
Oct 15, 2024 DOCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 8, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 8, 2023 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 3, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 16, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 16, 2023 OPNR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 11, 2023 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 10, 2023 RCSC
NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 29, 2023 NREP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 15, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 15, 2022 GNSL
SUSPENSION LETTER WRITTEN
Sep 15, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 14, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 13, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 13, 2022 TROA
REFUSAL PROCESSED BY IB
Jun 7, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 16, 2022 RFCS
REFUSAL PROCESSED BY MPU
May 16, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 3, 2022 RFCR
NON-FINAL ACTION WRITTEN
Apr 2, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 31, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 22, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 10, 2022 REPR